Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Clark

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Anesthesia and Analgesia|November 1, 1985
Effects of glycine on hemodynamic responses and visual evoked potentials in the dogJ M Wang, K C Wong, D J Creel, et al.
Organic Letters|June 3, 2000
A highly enantioselective conjugate reduction of 3-arylinden-1-ones using bakers' yeast for the preparation of (S)-3-arylindan-1-onesW M Clark, A J Kassick, M A Plotkin, et al.
Neurology|September 26, 1997
A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study GroupW M Clark, S J Warach, L C Pettigrew, et al.
Stroke|November 1, 1990
Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]P D Lyden, K P Madden, W M Clark, et al.
Stroke|April 3, 2001
Efficacy of antioxidant therapies in transient focal ischemia in miceW M Clark, L G Rinker, N S Lessov, et al.
Radiology|April 1, 1980
Ultrasound patterns of disorders affecting the gastrointestinal tractC L Morgan, W S Trought, T A Oddson, et al.
Annals of Neurology|June 1, 1995
Interleukin-6 and interleukin-1 receptor antagonist in acute strokeN B Beamer, B M Coull, W M Clark, et al.
Stroke|July 1, 1994
Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatmentW M Clark, F A Calcagno, W L Gabler, et al.
Journal of Clinical Ultrasound : JCU|December 1, 1978
Principles and applications of a dynamically focused phased array real time ultrasound systemC L Morgan, W S Trought, W M Clark, et al.
JAMA|December 11, 1999
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic StrokeW M Clark, S Wissman, G W Albers, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Anesthesia and Analgesia|November 1, 1985
Effects of glycine on hemodynamic responses and visual evoked potentials in the dogJ M Wang, K C Wong, D J Creel, et al.
Organic Letters|June 3, 2000
A highly enantioselective conjugate reduction of 3-arylinden-1-ones using bakers' yeast for the preparation of (S)-3-arylindan-1-onesW M Clark, A J Kassick, M A Plotkin, et al.
Neurology|September 26, 1997
A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study GroupW M Clark, S J Warach, L C Pettigrew, et al.
Stroke|November 1, 1990
Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]P D Lyden, K P Madden, W M Clark, et al.
Stroke|April 3, 2001
Efficacy of antioxidant therapies in transient focal ischemia in miceW M Clark, L G Rinker, N S Lessov, et al.
Radiology|April 1, 1980
Ultrasound patterns of disorders affecting the gastrointestinal tractC L Morgan, W S Trought, T A Oddson, et al.
Annals of Neurology|June 1, 1995
Interleukin-6 and interleukin-1 receptor antagonist in acute strokeN B Beamer, B M Coull, W M Clark, et al.
Stroke|July 1, 1994
Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatmentW M Clark, F A Calcagno, W L Gabler, et al.
Journal of Clinical Ultrasound : JCU|December 1, 1978
Principles and applications of a dynamically focused phased array real time ultrasound systemC L Morgan, W S Trought, W M Clark, et al.
JAMA|December 11, 1999
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic StrokeW M Clark, S Wissman, G W Albers, et al.
Pageof 10